Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose nalmefene combined with opioids for postoperative analgesia after laparoscopic gastrointestinal surgery
ChiCTR2100047746Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalmefene in postoperative pain (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Incidence of major side effects of opioid analgesia and Opioid consumption. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
nalmefene
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100047746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047746.